Aroa Biosurgery Limited (ASX:ARX)
Australia · Delayed Price · Currency is AUD 0.6450
-0.0150 (-2.27%)
Jun 5, 2026, 3:32 PM AEST
Aroa Biosurgery Income Statement
Financials in millions NZD. Fiscal year is April - March.
Millions NZD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 103.85 | 84.7 | 69.07 | 63.36 | 39.68 | |
Revenue Growth (YoY) | 22.62% | 22.63% | 9.01% | 59.68% | 77.60% |
Cost of Revenue | 15.03 | 12.08 | 10.09 | 9.88 | 9.38 |
Gross Profit | 88.83 | 72.61 | 58.97 | 53.48 | 30.3 |
Selling, General & Admin | 76.27 | 67.05 | 62.15 | 47.71 | 30.71 |
Research & Development | 7.93 | 9.57 | 9.16 | 10.61 | 8.35 |
Other Operating Expenses | -1.05 | -1.08 | -1.66 | -1.73 | -1.12 |
Operating Expenses | 83.15 | 75.53 | 69.64 | 56.59 | 37.95 |
Operating Income | 5.68 | -2.92 | -10.67 | -3.11 | -7.64 |
Interest Expense | -0.47 | -0.48 | -0.49 | -0.38 | -1.15 |
Interest & Investment Income | 0.68 | 1.06 | 1.8 | 1.32 | 0.4 |
Currency Exchange Gain (Loss) | -0.61 | -0.9 | -1.05 | 1.8 | 0.13 |
Other Non Operating Income (Expenses) | -0.01 | -0.01 | -0.01 | -0.01 | -0 |
EBT Excluding Unusual Items | 5.27 | -3.25 | -10.43 | -0.38 | -8.26 |
Pretax Income | 5.27 | -3.25 | -10.43 | -0.38 | -8.26 |
Income Tax Expense | 0.6 | 0.56 | 0.2 | 0.01 | 0.13 |
Net Income | 4.68 | -3.81 | -10.63 | -0.4 | -8.39 |
Net Income to Common | 4.68 | -3.81 | -10.63 | -0.4 | -8.39 |
Shares Outstanding (Basic) | 345 | 345 | 344 | 343 | 342 |
Shares Outstanding (Diluted) | 363 | 345 | 344 | 343 | 342 |
Shares Change (YoY) | 5.39% | 0.31% | 0.27% | 0.22% | 13.90% |
EPS (Basic) | 0.01 | -0.01 | -0.03 | -0.00 | -0.02 |
EPS (Diluted) | 0.01 | -0.01 | -0.03 | -0.00 | -0.02 |
Free Cash Flow | 9.44 | -4.88 | -10.9 | -9.8 | -15.98 |
Free Cash Flow Per Share | 0.03 | -0.01 | -0.03 | -0.03 | -0.05 |
Gross Margin | 85.53% | 85.73% | 85.39% | 84.40% | 76.37% |
Operating Margin | 5.47% | -3.45% | -15.45% | -4.91% | -19.26% |
Profit Margin | 4.50% | -4.50% | -15.39% | -0.63% | -21.13% |
Free Cash Flow Margin | 9.09% | -5.76% | -15.78% | -15.47% | -40.27% |
EBITDA | 8.84 | 0.26 | -7.4 | -0.08 | -5.29 |
EBITDA Margin | 8.51% | 0.30% | -10.71% | -0.13% | -13.32% |
D&A For EBITDA | 3.16 | 3.17 | 3.28 | 3.03 | 2.36 |
EBIT | 5.68 | -2.92 | -10.67 | -3.11 | -7.64 |
EBIT Margin | 5.47% | -3.45% | -15.45% | -4.91% | -19.26% |
Effective Tax Rate | 11.28% | - | - | - | - |